Rare Head & Neck Tumors – Clinical Trials – Immunotherapy

Working Group

Rare Head & Neck Tumors – Clinical Trials – Immunotherapy

This Working Group focuses on the multidisciplinary approach and scientific study of rare head and neck tumors, with special emphasis on clinical research, innovative therapeutic strategies and the evolving field of immunotherapy.

01

Mission of the Group

The group was established to promote scientific collaboration, research initiatives and knowledge exchange regarding rare head and neck tumors, while supporting advances in oncology and supportive patient care.

02

Research Areas

  • Clinical trials and modern therapeutic protocols
  • Immunotherapy and targeted treatments
  • Multidisciplinary collaboration in head & neck oncology
  • Supportive care and patient quality of life

Working Group Leadership

Chair

Amanda Psyrri

Vice Chair

—

Members
  • Ourania Nicolatou-Galitis
  • —